{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:06:42Z","timestamp":1777514802391,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Fixed combination calcipotriol 50 \u00b5g\/g (Cal; as hydrate) plus betamethasone 0.5 mg\/g (as dipropionate; BD) has been formulated in an innovative aerosol foam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To assess systemic safety of Cal\/BD aerosol foam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In a multicentre, single-arm, open-label, maximal-use systemic-exposure trial, adult patients with moderate to severe, extensive psoriasis (15%-30% of body surface area, including \u226530% of scalp) applied Cal\/BD foam once daily. Endpoints were week 4 abnormal adrenocorticotropic hormone (ACTH) challenge test and change in albumin-corrected serum calcium, 24-hour urinary calcium excretion, and urinary calcium-creatinine ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>35 patients reaching week 4 exhibited normal ACTH responses. At week 4, changes in calcium homeostasis were minor and not clinically relevant; no patients experienced elevations above normal. Disease severity generally improved, and 49% of patients achieved treatment success according to the Physician\u2019s Global Assessment of Disease Severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>No clinically relevant HPA axis or calcium homeostasis impact was observed with 4 weeks of once-daily Cal\/BD foam in patients with extensive psoriasis vulgaris.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1203475415597094","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T23:14:09Z","timestamp":1438211649000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris"],"prefix":"10.1177","volume":"20","author":[{"given":"Victoria","family":"Taraska","sequence":"first","affiliation":[{"name":"The Derm Centre, Winnipeg, MB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Tuppal","sequence":"additional","affiliation":[{"name":"Oshawa Clinic, Oshawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Olesen","sequence":"additional","affiliation":[{"name":"LEO Pharma A\/S, Ballerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Bang Pedersen","sequence":"additional","affiliation":[{"name":"LEO Pharma A\/S, Ballerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Papp","sequence":"additional","affiliation":[{"name":"K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"bibr1-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"bibr2-1203475415597094","unstructured":"World Health Assembly. Psoriasis. Agenda item 13.5. WHA67.9. 2014. http:\/\/appswhoint\/gb\/ebwha\/pdf_files\/WHA67\/A67_R9-en.pdf. Accessed February 26, 2015."},{"key":"bibr3-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03705.x"},{"key":"bibr4-1203475415597094","doi-asserted-by":"publisher","DOI":"10.2165\/11591580-000000000-00000"},{"key":"bibr5-1203475415597094","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1193"},{"key":"bibr6-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1080-1"},{"key":"bibr7-1203475415597094","first-page":"609","volume":"147","author":"Girolomoni G","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"bibr8-1203475415597094","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2011.10066"},{"key":"bibr9-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12058"},{"key":"bibr10-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0948"},{"key":"bibr11-1203475415597094","doi-asserted-by":"publisher","DOI":"10.2165\/11207300-000000000-00000"},{"key":"bibr12-1203475415597094","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72451"},{"key":"bibr13-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04523.x"},{"key":"bibr14-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30290-0"},{"key":"bibr15-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.028"},{"key":"bibr16-1203475415597094","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/jid.2013.286","volume":"134","author":"Hollesen Basse L","year":"2014","journal-title":"J Invest Dermatol"},{"key":"bibr17-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0269-7"},{"key":"bibr18-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07236.x"},{"key":"bibr19-1203475415597094","first-page":"882","volume":"12","author":"Silver S","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"bibr20-1203475415597094","first-page":"969","volume":"9","author":"Fleming C","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"bibr21-1203475415597094","unstructured":"FDA. FDA guidance to industry. Acne vulgaris: developing drugs for treatment. 2005. http:\/\/wwwfdagov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM071292.pdf. Accessed June 5, 2014."},{"key":"bibr22-1203475415597094","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948194"},{"key":"bibr23-1203475415597094","volume-title":"Paper presented at: 73rd Annual Meeting of the American Academy of Dermatology (AAD)","author":"Lebwohl M"},{"key":"bibr24-1203475415597094","volume-title":"Abstract presented at: Skin Disease Education Foundation\u2019s 39th Annual Hawaii Dermatology Seminar","author":"Koo J"},{"key":"bibr25-1203475415597094","first-page":"327","volume":"70","author":"Housman TS","year":"2002","journal-title":"Cutis"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475415597094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1203475415597094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475415597094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:53:18Z","timestamp":1777391598000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1203475415597094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1177\/1203475415597094"],"URL":"https:\/\/doi.org\/10.1177\/1203475415597094","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}